BRIEF-FDA Grants Fanapt 3 years of marketing exclusivity for labeling changes
June 15, 2016 at 07:34 AM EDT
* FDA grants Fanapt three years of marketing exclusivity for labeling changes relating to maintenance treatment of schizophrenia Source text for Eikon: Further company coverage:
